New Class Of Antigens Might Help In Diagnosis And Treatment

the-new-antigens-result-in-the-formation-of-hybrid-insulin-peptides

Original article written by R. Siva Kumar for Counsel & Heal on February 15, 2016. Click here to read the original article.

A novel class of antigens might help scientists to understand why type 1 diabetes develop, finds research from a University of Colorado Denver.

This type of diabetes has the immune system turning against the body’s own tissues. The type 1 diabetes shows that insulin-producing beta cells identified in the pancreas are hit by immune cells, especially T cells.

The insulin is a hormone vital for maintaining blood glucose, and without it, things can become threatening for life. Results can help scientists to invent the first-ever cure for this form of diabetes.

“Our lab studies the type of T cell known as a CD4 T cell,” Kathryn Haskins, corresponding author of the article, said in a press release. “We have focused on autoreactive CD4 T cells using a mouse model of autoimmune diabetes. We have been especially interested in identifying the antigens that activate these T cells.”

Such antigens can also help to find autoreactive T cells in the early stage of the disease and in those who are at risk. It helps in the identification and treatment too. By developing a way of turning off harmful T cells, they may be able to prevent the illness.

There may be some modified peptides that are called “foreign” to the human immune system. Some of these become targets for autoreactive T cells. Other autoimmune diseases can also be understood through them.

The study was published in the Feb. 12, 2016 issue of Science.

Related News

Genetics in T1D

DRC’s Take on, “The type 1 diabetes gene TYK2 regulates βcell development and its responses to interferon-α”

Learn More +

DRC Is Excited to Share This Breaking T1D News Announced Yesterday by the FDA

Learn More +

November 2022 Newsletter

Learn More +